Novavax has signed a memorandum of understanding (MOU) with the vaccine alliance, Gavi, to provide 1.1 billion doses of its recombinant protein-based COVID-19 …
Novavax (NVAX) has signed a non-binding heads of terms document with the Australian Government to supply 40 million doses of the company’s COVID-19 …
Shares of Novavax are down more than 6% as the drugmaker delayed the start of the US late-stage trial of its COVID-19 vaccine …
Novavax said on Friday that the US drug developer has entered into a purchase agreement with the UK government for the supply of …
Shares in Novavax (NVAX) rose 5% in Monday’s trading after the late-stage biotech announced positive second quarter earning results. However the stock subsequently …
Biotech Novavax (NVAX) has announced that the U.S.
Novavax (NVAX) on Wednesday announced the acquisition of Praha Vaccines to help the late-stage biotech company produce over 1 billion doses of its …
Novavax (NVAX) is now beginning human testing in its Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373. Preliminary immunogenicity and safety …
Novavax (NVAX) filed a prospectus to sell up to $250 million of shares of common stock as it prepares to scale up production …
Novavax Inc. (NVAX) jumped 31% after the late-stage biotech company said it will receive $384 million in funding from the Coalition for Epidemic …
